Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

January 31, 2012

Conditions
Sarcoma
Interventions
DRUG

trabectedin

Trial Locations (32)

10021

Memorial Sloan-Kettering Cancer Center, New York

11203

SUNY Downstate Medical Center, Brooklyn

19001

Rosenfeld Cancer Center at Abington Memorial Hospital, Abington

20010

Washington Cancer Institute at Washington Hospital Center, Washington D.C.

27710

Duke Comprehensive Cancer Center, Durham

30912

MBCCOP - Medical College of Georgia Cancer Center, Augusta

31201

Central Georgia Gynecologic Oncology, Macon

44060

Lake/University Ireland Cancer Center, Mentor

44109

MetroHealth Cancer Care Center at MetroHealth Medical Center, Cleveland

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

45409

David L. Rike Cancer Center at Miami Valley Hospital, Dayton

46260

St. Vincent Indianapolis Hospital, Indianapolis

60521

Hinsdale Hematology Oncology Associates, Hinsdale

65804

St. John's Regional Health Center, Springfield

73104

Oklahoma University Cancer Institute, Oklahoma City

89102

Women's Cancer Center - Lake Mead, Las Vegas

90089-9181

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

06102-5037

Helen and Harry Gray Cancer Center at Hartford Hospital, Hartford

06050

George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus, New Britain

31403-3089

Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah

60611-3013

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

52242-1002

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

49007-3731

West Michigan Cancer Center, Kalamazoo

87131-5636

University of New Mexico Cancer Center, Albuquerque

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

28232-2861

Blumenthal Cancer Center at Carolinas Medical Center, Charlotte

28233-3549

Presbyterian Cancer Center at Presbyterian Hospital, Charlotte

44106-5065

Case Comprehensive Cancer Center, Cleveland

43210-1240

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus

43214-3998

Riverside Methodist Hospital Cancer Care, Columbus

53792-6164

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00379145 - Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus | Biotech Hunter | Biotech Hunter